Join us for the European Pharma Days taking place on April 27 - 28 in Mannheim, Germany, organized by Bruker, M2Aind and CeMOS – Center for Mass Spectrometry and Optical Spectroscopy.
Join several industry leaders from top pharma around the globe as they present their perspectives on advanced MS based technologies like trapped ion mobility and MALDI Imaging and how these new technologies are transforming drug discovery. This two day event will cover applications within biologics characterization (day 1) and MALDI Imaging (day 2) with speakers from Novozymes, Janssen, Octapharma, Boehringer Ingelheim, Sanofi, Ambergen and PreOmics.
From lead generation to pre-clinical assessment, Bruker has built on years of excellence in mass spectrometry to impact the pharmaceutical industry. It is a great opportunity to learn from key users in the industry how to maximize these new workflows.
Aula, Building C
Mannheim University of Applied Sciences
Hochschule Mannheim
Paul-Wittsack-Straße 10
68163 Mannheim
10:00 - 11:00 Registration
11:00 - 11:10 Opening
Prof. Dr. Mathias Hafner, VP Research and Transfer, Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany
Dr. Eric van Beelen, Bruker Netherland B.V., Leiderdorp, Netherlands
Chair: Prof. Dr. Carsten Hopf, Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany
11:10 - 12:00 Keynote Speaker: Prof. Dr. Matthias Mann, Max-Planck-Institute for Biochemistry, Martinsried, Germany
12:00 - 13:30 Lunch Break
Chair: Dr. Christian Albers, Bruker Daltonics GmbH & Co. KG, Bremen, Germany
13:30 - 14:00 Complementary MS method for assessing structural changes in monoclonal antibodies
Manasi Gaikwad – Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany
14:00 - 14:20 PreON: Highly efficient automated LC/MS sample preparation up and running in your facilities within one day
Russel Golson, PreOmics, München, Germany
14:20 - 14:50 High-Throughput Host Cell Protein Analysis in Industrial Biotechnology
Dr. Christian Jörgensen, Novozymes A/S, Bagsvaerd, Denmark
14:50 - 15:20 In-depth characterization of therapeutic oligonucleotides by timsTOF pro and Bruker OligoQuest
Dr. Youzhong Lui, Janssen Pharmaceuticals, Beerse, Belgium
15:20 - 15:50 Break
Chair: Mike Greig, Bruker Scientific LLC, Billerica, US
16:50 - 16:20 Termini-dissected characterization of protein-based biologic by TIMS-enabled Next-Generation MALDI Top-Down sequencing
Dr. Arndt Asperger, Bruker Daltonics GmbH & Co. KG, Bremen, Germany
16:20 - 16:50 Characterization of antigenic glycoproteins
Dr. Michel Plisnier, GSK, Rixensart, Belgium
16:50 - 17:20 Assessing the Immunogenicity of Biopharmaceuticals using immunopeptidomics
Dr. Duong Nguyen, Octapharma Biopharmaceuticals GmbH, Berlin, Germany
17:20 - 17:50 High resolution intact and sub-unit protein mass spectrometry for the characterization of biopharmaceuticals
Dr. Christopher Lößner, Boehringer Ingelheim, Biberach, Germany
17:50 - 19:00 Networking
Chair: Dr. Naomi Vos, Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany
9:00 - 09:50 Keynote Speaker: Dr. Peter Marshall, GSK, Stevenage, United Kingdom
09:50 - 10:30 Coffee Break
Chair: Dr. Mike Easterling, Bruker Scientific LLC, Billerica, US
10:30 - 11:00 The “I” is for Imaging… MSI application examples in pharmaceutical Research and Development
Dr. Michael Becker – Boehringer Ingelheim, Biberach, Germany
11:00 - 11:30 Spatial omics to investigate intra-tumor heterogeneity of sulfatides in cholangiocarcinoma
Kasper Krestensen, M4I-University of Maastricht, Netherlands
11:30 - 12:00 Biomarker discovery at Sanofi: Linking untargeted biomarker discovery with UHR-MALDI- Imaging
Dr. Bogdan Muntenau, Sanofi, Frankfurt, Germany
12:00 - 13:30 Lunch Break (and Tours of the Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), MSI Facility)
Chair: Dr. Alexandra Iakab, Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany
13:30 - 14:00 FROM LABORATORY TO HOSPITAL: Empowering clinical diagnostics with translational Mass Spectrometry Imaging
Dr. Eva Cuypers, M4I-University of Maastricht, Maastricht, Netherlands
14:00 - 14:30 TIMI - Tissue Imaging using MALDI and Immunohistochemistry
Dr. Mark Lim, Ambergen, Watertown, US
14:30 - 15:00 Coffee Break
Chair: Dr. Michele Genangeli, Bruker Nederland B.V., Leiderdorp, Netherlands
15:00 - 15:30 Assessing small molecule distributions in 3D cell culture models by 3D-MALDI Imaging
Dr. Alexandra Iakab, Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany
15:30 - 16:00 Insights into Alzheimer Pathology Using Multimodal Chemical Imaging
Dr. Jörg Hanrieder, Department of Psychiatry and Neurochemistry, University of Gothenburg, Sweden
16:00 - 16:15 Closing remarks
Dr. Eric van Beelen, Bruker Nederland B.V., Leiderdorp, Netherlands
For further information, please contact:
Anne Kropp
Bruker Daltonics GmbH & Co. KG
Fahrenheitstrasse 4
28359 Bremen
anne.kropp@bruker.com
For Research Use Only. Not for use in clinical diagnostic procedures.